US BANCORP \DE\ - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 287 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.8%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$46,000
-63.8%
306
-65.0%
0.00%
Q2 2022$127,000
+81.4%
874
+49.1%
0.00%
Q1 2022$70,000
+2.9%
586
+19.1%
0.00%
Q4 2021$68,000
+580.0%
492
+593.0%
0.00%
Q3 2021$10,000
+900.0%
71
+688.9%
0.00%
Q2 2021$1,0000.0%9
-30.8%
0.00%
Q1 2021$1,000
-96.0%
13
-95.4%
0.00%
Q4 2020$25,000
+2400.0%
284
+2740.0%
0.00%
Q4 2019$1,000100.0%0.00%
Q3 2019$0
-100.0%
10
-96.5%
0.00%
Q2 2019$12,000
+300.0%
288
+433.3%
0.00%
Q1 2019$3,000540.00%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q4 2021
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 900,844$136,181,00079.57%
RP Management, LLC 1,111,111$167,967,00077.60%
JET CAPITAL INVESTORS L P 1,707,500$258,942,00053.95%
Alpine Global Management, LLC 373,999$56,537,00013.23%
Chicago Capital Management, LLC 154,585$23,443,00012.75%
FIFTH LANE CAPITAL, LP 140,000$21,164,00011.03%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 3,784,482$572,100,000,00010.85%
Eversept Partners, LP 637,139$96,316,3038.35%
EQUITEC PROPRIETARY MARKETS, LLC 187,100$28,284,0007.45%
HARVEST MANAGEMENT LLC 48,503$7,332,0005.92%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders